Dr. Stephen E. Wolverton, MD

Expert Publications

• Monitoring for adverse effects from systemic drugs used in dermatology.
• Pemphigus foliaceus with epidermal detachment: adverse events from patch testing.
• Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugs.
• The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
• Optimizing clinical use of azathioprine with newer pharmacogenetic data.
• Controversies in dermatologic drug therapy.
• Can short courses of systemic corticosteroids truly cause osteonecrosis?
• Moxifloxacin-induced drug hypersensitivity syndrome with features of toxic epidermal necrolysis.
• Systemic drug therapy for psoriasis. The most critical issues.
• Recent trends in systemic psoriasis treatment costs.
• Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
• Top-accessed article: topical rapamycin.
• Drug hypersensitivity syndrome in a patient receiving vismodegib.
• Practice Gaps: Drug Reactions.
• Medical Malpractice in Dermatology-Part I: Reducing the Risks of a Lawsuit.

Media Releases

Get to know Dermatologist Dr. Stephen E. Wolverton, who serves the population of Indianapolis, Indiana.

Stephen E. Wolverton, MD is a dermatologist currently practicing with Indiana University Health. Indiana University Health is the largest network of physicians in the state of Indiana. A unique partnership with Indiana University School of Medicine, one of the nation’s leading medical schools, gives patients access to leading-edge medicine and treatment options that are available first, and often only, at IU Health.

After receiving his undergraduate degree at Ball State University in 1975, Dr. Wolverton attended medical school at Indiana University School of Medicine and received his MD degree in 1979.  Dr. Wolverton initially pursued a career in Family Practice, completing his residency at St. Elizabeth Medical Center in Dayton, Ohio in 1982. This residency was followed by a year in a junior faculty position at the same FP residency program.

Dr. Wolverton initiated his Dermatology career completing his residency at Wright State University in Dayton, Ohio, from 1983 to 1985. Subsequent faculty positions have included Wright State University (Fellow Instructor 1986-1987), Ohio State University (1987-1990, including a year as Acting Division Director), and the long-term faculty position in the Dermatology Department at the Indiana University School of Medicine (1990-present). His current position is Theodore Arlook Professor of Clinical Dermatology and Professor of Clinical Dermatology.

Dr. Wolverton’s long-term academic interest has been systemic drug use in Dermatology, focusing on all aspects of Drug Safety, including a more recent focus in the complex area of Drug Interactions. He is best known for his series of four books concerning Dermatologic Drug Therapy: Systemic Drugs for Skin Diseases (published in 1991) and Comprehensive Dermatologic Drug Therapy (initially published in 2001, 2nd edition published in February 2007, with the 3rd edition of this title published late Fall 2012).

In addition, for 20 years he has been the Course Director for the Introduction to Cutaneous Biology course for Dermatology residents throughout the US and Canada that is sponsored by the Indiana University Department of Dermatology. 

He is a frequent visiting professor at various Dermatology residency programs, along with various state and local Dermatologic medical societies. He continues his strong interest in Dermatology resident education full-time at IU and during many of the visiting professorships.

Dermatology is the branch of medicine dealing with the skin, nails, hair and its diseases. It is a specialty with both medical and surgical aspects. A dermatologist treats diseases, in the widest sense, as well as some cosmetic problems of the skin, scalp, hair, and nails.

Recommended Articles

• 5 Tips on Living with Melanoma

  Melanoma is a type of lethal skin cancer. Often developing from a mole, it is caused by mutation of the skin cells due to damage in their DNA. These mutations result in a tumor formation within the cells that contain melanin (the pigment that gives skin its color) in the epidermis. The color of a...

• How is Genital Herpes Diagnosed?

  Genital Herpes is the most common sexually transmitted disease. It is caused by two types of viruses - herpes simplex Type 1 and herpes simplex Type 2. However, people suffering from the condition are not aware of it because it hardly presents with any symptoms. So, in most of the cases people are...

• What are the Topical Treatments for Psoriasis?

  The most popular treatment options for psoriasis are topical applications, like creams, lotions, and foams. These formulations are applied on the skin or scalp directly to reduce the symptoms. There are a number of options available for the treatment of psoriasis are unique to each individual who...

• What is Chicken Pox: Get the Facts

  Chicken pox, also known as varicella, is a very contagious disease that is caused by presence of the varicella zoster virus (VZV). The most typical and characteristic sign of chicken pox is itchy bright red blisters all over the body. The varicella vaccine protects about 70-90% of the people who get...

• The Best Anti-Aging Tips

  Experts in the field of anti-aging believe that it is never too late to start the anti-aging essentials. Although it is not very obvious, the skin actually starts aging by mid-20's. The major factors that really make a difference for the killing looks are genes, daily skin routine, and sun...

• 5 Things to Avoid if You are Prone to Acne

  1. Sugar: According to research, high glycemic index (GI) foods (sugary foods) cause the body to produce a hormone called insulin-like growth factor 1 (IGF-1). This hormone tells the body to produce more sebum, which makes the acne worse. It makes pores appear larger as well. So simply switching...